Clinical feature	Statistical test	Significant miRs	Associated with	               	Associated with	
Time from Specimen Diagnosis to Death	Cox regression test	N=12	shorter survival	N=2	longer survival	N=10
Time to Death	Cox regression test	N=2	shorter survival	N=2	longer survival	N=0
AGE	Spearman correlation test	N=2	older	N=0	younger	N=2
PRIMARY SITE OF DISEASE	Kruskal-Wallis test	N=44	 	 	 	 
NEOPLASM DISEASESTAGE	Kruskal-Wallis test	N=0	 	 	 	 
PATHOLOGY T STAGE	Spearman correlation test	N=7	higher stage	N=3	lower stage	N=4
PATHOLOGY N STAGE	Spearman correlation test	N=3	higher stage	N=2	lower stage	N=1
PATHOLOGY M STAGE	Kruskal-Wallis test	N=0	 	 	 	 
MELANOMA ULCERATION	Wilcoxon test	N=1	yes	N=1	no	N=0
MELANOMA PRIMARY KNOWN	Wilcoxon test	N=0	 	 	 	 
BRESLOW THICKNESS	Spearman correlation test	N=5	higher breslow.thickness	N=3	lower breslow.thickness	N=2
GENDER	Wilcoxon test	N=1	male	N=1	female	N=0
RACE	Kruskal-Wallis test	N=0	 	 	 	 
ETHNICITY	Wilcoxon test	N=0